Full Product Name
Rabbit Polyclonal to Human GDF1
Product Synonym Names
Anti-GDF1 Antibody (N-Terminus) IHC-plus; GDF1; DTGA3; DORV; GDF-1; Human GDF1
Product Gene Name
anti-GDF1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P27539
Specificity
Human GDF1. GDF1 antibody is predicted to not cross-react with any other members of the growth differentiation factor family.
Purity/Purification
Immunoaffinity Purified
Form/Format
PBS, 0.02% sodium azide
Concentration
1 mg/ml (lot specific)
Immunogen Description
A 16 amino acid peptide near the amino terminus of human GDF1.
Immunogen Type
Synthetic peptide
Immunogen
GDF1 antibody was raised against a 16 amino acid peptide near the amino terminus of human GDF1.
Antigen Modification
N-Terminus
Preparation and Storage
Long term: -20 degree C; Short term: +4 degree C. Avoid repeat freeze-thaw cycles.
Other Notes
Small volumes of anti-GDF1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Product Categories/Family for anti-GDF1 antibody
Family: TGF beta
Applications Tested/Suitable for anti-GDF1 antibody
Immunohistochemistry (IHC - Paraffin), Western Blot (WB)
Application Notes for anti-GDF1 antibody
IHC-P (5 ug/ml), WB (1 - 2 ug/ml)
Usage: GDF1 antibody can be used for detection of GDF1 by Western blot at 1-2 ug/mL.
Immunohistochemistry (IHC) of anti-GDF1 antibody
Human, Small Intestine: Formalin-Fixed Paraffin-Embedded (FFPE)

Immunofluorescence (IF) of anti-GDF1 antibody
Immunofluorescence of GDF1 in human lung tissue with GDF1 antibody at 20 ug/ml.

Western Blot (WB) of anti-GDF1 antibody
Western blot analysis of GDF1 in rat lung tissue lysate with GDF1 antibody at (A) 1 and (B) 2 ug/ml.

NCBI/Uniprot data below describe general gene information for GDF1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001483.3
[Other Products]
NCBI GenBank Nucleotide #
NM_001492.5
[Other Products]
UniProt Primary Accession #
P27539
[Other Products]
UniProt Secondary Accession #
O43344[Other Products]
UniProt Related Accession #
P27539[Other Products]
Molecular Weight
39,475 Da
NCBI Official Full Name
embryonic growth/differentiation factor 1
NCBI Official Synonym Full Names
growth differentiation factor 1
NCBI Official Symbol
GDF1??[Similar Products]
NCBI Official Synonym Symbols
RAI; DORV; DTGA3
??[Similar Products]
NCBI Protein Information
embryonic growth/differentiation factor 1; GDF-1
UniProt Protein Name
Embryonic growth/differentiation factor 1
Protein Family
Embryonic growth/differentiation factor
UniProt Gene Name
GDF1??[Similar Products]
UniProt Synonym Gene Names
GDF-1??[Similar Products]
UniProt Entry Name
GDF1_HUMAN
NCBI Summary for GDF1
This gene encodes a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This group of proteins is characterized by a polybasic proteolytic processing site that is cleaved to produce a mature protein containing seven conserved cysteine residues. The members of this family are regulators of cell growth and differentiation in both embryonic and ***** tissues. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. This protein is transcribed from a bicistronic mRNA that also encodes the longevity assurance gene. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Mar 2014]
UniProt Comments for GDF1
GDF1: May mediate cell differentiation events during embryonic development. Defects in GDF1 are a cause of conotruncal heart malformations (CTHM). A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. Defects in GDF1 are the cause of transposition of the great arteries dextro-looped type 3 (DTGA3). A congenital heart defect consisting of complete inversion of the great vessels, so that the aorta incorrectly arises from the right ventricle and the pulmonary artery incorrectly arises from the left ventricle. This creates completely separate pulmonary and systemic circulatory systems, an arrangement that is incompatible with life. The presence or absence of associated cardiac anomalies defines the clinical presentation and surgical management of patients with transposition of the great arteries. Defects in GDF1 are a cause of tetralogy of Fallot (TOF). A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. Belongs to the TGF-beta family.
Protein type: Secreted, signal peptide; Secreted
Chromosomal Location of Human Ortholog: 19p12
Cellular Component: extracellular space
Molecular Function: growth factor activity; cytokine activity; transforming growth factor beta receptor binding
Biological Process: BMP signaling pathway; regulation of apoptosis; regulation of MAPKKK cascade; cell development; growth
Disease: Transposition Of The Great Arteries, Dextro-looped 3; Right Atrial Isomerism; Conotruncal Heart Malformations; Tetralogy Of Fallot
Research Articles on GDF1
1. This implies that Gdf1 potentiates Nodal activity by stabilizing a low molecular weight fraction that is susceptible to neutralization by soluble Acvr2.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.